Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 20

Sort by

Sort Order Select

Journal Articles

Body Mass Index and Clinical Factors Associated with Monoclonal Gammopathy of Undetermined Significance (MGUS) Progression in Olmsted County, Minnesota

Geffen Kleinstern, PhD, Dirk Larson, MS, Cristine Allmer, BS, Aaron D. Norman, MPH, Jason P Sinnwell, MS, S. Vincent Rajkumar, MD, Angela Dispenzieri, MD, Robert A. Kyle, MD, Susan L. Slager, PhD, Shaji K. Kumar, MD, Celine M. Vachon, PhD

Blood (2020) 136 (Supplement 1): 15–16.

https://doi.org/10.1182/blood-2020-136894

Published: 2020

Journal Articles

Prevalence of Familial Plasma Cell Disorders in Patients with Multiple Myeloma

Alissa Visram, MD, Eli Muchtar, MD, S. Vincent Rajkumar, MD, Celine M. Vachon, PhD, Angela Dispenzieri, MD, Prashant Kapoor, MD, Martha Q. Lacy, MD, Francis K. Buadi, MB, CHB, Suzanne R. Hayman, MD, Morie A. Gertz, MD, Robert A. Kyle, MD, Shaji K. Kumar, MD

Blood (2020) 136 (Supplement 1): 1–2.

https://doi.org/10.1182/blood-2020-143098

Published: 2020

Journal Articles

Comparison of MGUS Prevalence By Race and Family History Risk Groups Using a High Sensitivity Screening Method (MASS-FIX)

Celine M. Vachon, PhD, Josiah Murray, Cristine Allmer, BS, Dirk Larson, MS, Aaron D. Norman, MPH, Jason P Sinnwell, MS, Angela Dispenzieri, MD, Geffen Kleinstern, PhD, Robert A. Kyle, MD, S. Vincent Rajkumar, MD, Susan L. Slager, PhD, Shaji K. Kumar, MD, David L. Murray, MDPhD

Blood (2020) 136 (Supplement 1): 40–41.

https://doi.org/10.1182/blood-2020-142583

Published: 2020

Journal Articles

Polygenic Risk Score and Risk of Chronic Lymphocytic Leukemia, Monoclonal B-Cell Lymphocytosis (MBL), and MBL Subtypes

Geffen Kleinstern, PhD, J. Brice Weinberg, MD, Sameer A. Parikh, MD, Esteban Braggio, PhD, Dennis P. Robinson, Aaron D. Norman, MPH, Kari G Rabe, Celine M. Vachon, PhD, Connie E. Lesnick, Timothy G. Call, MD, Danielle M. Brander, MD, Janet E. Olson, PhD, James R. Cerhan, MD PhD, Neil E. Kay, MD, Curtis A. Hanson, MD, Richard R. Furman, MD, Tait Shanafelt, MD, Susan L. Slager, PhD

Blood (2020) 136 (Supplement 1): 35–36.

https://doi.org/10.1182/blood-2020-136548

Published: 2020

Journal Articles

The CCND1 870G Risk Allele Is Enriched in African Individuals with Plasma Cell Dyscrasias

Linda B Baughn, PhD, Zhou Li, MS, Kathryn E. Pearce, Celine M. Vachon, PhD, Mei-Yin Polley, PhD, Jonathan J Keats, PhD, Eran Elhaik, PhD, Michael L. Baird, PhD, Terry Therneau, PhD, James R. Cerhan, MD PhD, P. Leif Bergsagel, MD, Angela Dispenzieri, MD, S.Vincent Rajkumar, MD, Yan Asmann, PhD, Shaji K. Kumar, MD

Blood (2019) 134 (Supplement_1): 4362.

https://doi.org/10.1182/blood-2019-124979

Published: 2019

Journal Articles

Association between a Polygenic Risk Score for Multiple Myeloma Risk and Overall Survival

Blood (2019) 134 (Supplement_1): 4366.

https://doi.org/10.1182/blood-2019-126088

Published: 2019

Journal Articles

Germline Variation Predicts Treatment Response in Multiple Myeloma

Kyle Roter, BSc, Donglei Hu, PhD, Alyssa Clay-Gilmour, PhD, Scott Huntsman, Nina D. Shah, MD, Sandy W. Wong, MD, Thomas G. Martin, III, MD, Jeffrey Lee Wolf, MD, Moritz Binder, MDMPH, Shaji K. Kumar, MD, S. Vincent Rajkumar, MD, Susan L. Slager, PhD, Celine M. Vachon, PhD, Elad Ziv, MD

Blood (2019) 134 (Supplement_1): 4397.

https://doi.org/10.1182/blood-2019-129344

Published: 2019

Journal Articles

Tumor Mutational Load and Germline Polygenic Risk Score Predicts Time-to-First Treatment in Chronic Lymphocytic Leukemia (CLL) and High-Count Monoclonal B Cell Lymphocytosis (MBL)

Geffen Kleinstern, PhD, Daniel R O'Brien, Brian Kabat, B.S., Kari G Rabe, Aaron D. Norman, Huihuang Yan, PhD, Celine M. Vachon, PhD, Shulan Tian, MS, PhD, Timothy G. Call, MD, Sameer A. Parikh, MD, Jose F. Leis, MD PhD, Wei Ding, MD PhD, James R. Cerhan, MD PhD, Neil E. Kay, MD, Esteban Braggio, PhD, Susan L. Slager, PhD

Blood (2019) 134 (Supplement_1): 852.

https://doi.org/10.1182/blood-2019-124346

Published: 2019

Journal Articles

Large-Scale Linkage Analysis of Multiple Myeloma (MM) and Monoclonal Gammopathy of Undetermined Significance (MGUS) Families

Alyssa I. Clay-Gilmour, BS, PhD, Nicola J Camp, PhD, Xiaomu Wei, PhD, Aaron D. Norman, Jason P Sinnwell, MS, Delphine Demangel, Rosalie Griffin Waller, BS, Charles Dumontet, James McKay, Kenneth Offit, MD, Siwei Chen, Daniel R O'Brien, S. Vincent Rajkumar, MD, Robert Klein, PhD, Shaji K. Kumar, MD, Steven Lipkin, MD PhD, Susan L. Slager, PhD, Celine M. Vachon, PhD

Blood (2018) 132 (Supplement 1): 4501.

https://doi.org/10.1182/blood-2018-99-119320

Published: 2018

Journal Articles

Genomic Abnormalities Among African Individuals with Monoclonal Gammopathies Using Calculated Ancestry

Linda B Baughn, PhD, Dirk Larson, MS, Mei-Yin Polley, PhD, Kathryn E. Pearce, Eran Elhaik, PhD, Michael L. Baird, PhD, Colin Colby, Joanne Benson, Zhou Li, MS, Yan Asmann, PhD, Terry Therneau, PhD, James R. Cerhan, MD PhD, Celine M. Vachon, PhD, A Keith Stewart, MB, ChB, P. Leif Bergsagel, MD, Angela Dispenzieri, MD, Shaji K. Kumar, MD, S. Vincent Rajkumar, MD

Blood (2018) 132 (Supplement 1): 4458.

https://doi.org/10.1182/blood-2018-99-117382

Published: 2018

Journal Articles

Clonal Hematopoiesis of Indeterminate Potential (CHIP) and Chronic Lymphocytic Leukemia (CLL) Driver Genes: Risk of CLL and Monoclonal B-Cell Lymphocytosis (MBL)

Nicholas J Boddicker, PhD, Daniel R O'Brien, Esteban Braggio, PhD, Sara J. Achenbach, Kari G. Chaffee, MS, Aaron D. Norman, Celine M. Vachon, PhD, Brian Kabat, B.S., Timothy G. Call, MD, Sameer A. Parikh, MD, Jose F. Leis, MD PhD, Wei Ding, MD PhD, Eli Muchtar, MD, James R. Cerhan, MD PhD, Tait D. Shanafelt, MD, Neil E. Kay, MD, Neil E Caporaso, Susan L. Slager, PhD

Blood (2018) 132 (Supplement 1): 3116.

https://doi.org/10.1182/blood-2018-99-117044

Published: 2018

Journal Articles

Skin Cancers Among Chronic Lymphocytic Leukemia (CLL) Patients - the Effect of UV Radiation and CLL Clinical Characteristics

Geffen Kleinstern, PhD, Abdul Rishi, MBBS, Sara J Achenbach, Kari Rabe Chaffee, MS, Neil E. Kay, MD, Tait D. Shanafelt, MD, Aaron Norman, MPH, Celine M. Vachon, PhD, Timothy G. Call, MD, Christian L. Baum, MD, James R Cerhan, MD PhD, Susan L. Slager, PhD

Blood (2016) 128 (22): 4772.

https://doi.org/10.1182/blood.V128.22.4772.4772

Published: 2016

Journal Articles

Risk of Monoclonal Gammopathy of Undetermined Significance in First-Degree Relatives of Multiple Myeloma Cases By Cytogenetic Subtype

Alyssa I. Clay, PhD, Abdul Rishi, MBBS, Shaji Kumar, MD, S. Vincent Rajkumar, MD, Alexandra J. Greenberg, PhD MPH, Dirk R Larson, MS, Megan M. O'Byrne, MS, Susan L. Slager, PhD, Celine M. Vachon, PhD

Blood (2016) 128 (22): 4425.

https://doi.org/10.1182/blood.V128.22.4425.4425

Published: 2016

Journal Articles

Exome Sequencing in Chronic Lymphocytic Leukemia (CLL) and Multiple Myeloma (MM) Families Identifies Cosegregating Functional Variants

Sara Beiggi, PhD, Daniel R O'Brien, Sara J Achenbach, Kari G Rabe, MS, Timothy G Call, MD, Neil E Kay, MD, Tait D Shanafelt, MD, Aaron D Norman, MS, Julie M Cunningham, PhD, Vincent Rajkumar, MD, Shaji Kumar, MD, James R Cerhan, MD PhD, Celine M Vachon, PhD, Susan L Slager, PhD

Blood (2014) 124 (21): 1967.

https://doi.org/10.1182/blood.V124.21.1967.1967

Published: 2014

Journal Articles

Inherited Loss of Samsn1 Contributes to Increased Risk of MGUS and MM through Effects on Multiple Cell Types, Including B-Cells, Transformed Myeloma Cells, and Macrophages

Sarah Amend, PhD, William C Wilson, PhD, Liang Chu, PhD, Daniel Serie, PhD, Celine M Vachon, PhD, Lan Lu, MSci, Xinming Su, PhD, Michelle A Hurchla, Dingyan Wang, PhD, Pengyuan Liu, PhD, Ravi Vij, MD, Graham A Colditz, MD, Dr.PH., Katherine N Weilbaecher, MD, Michael H. Tomasson, MD

Blood (2014) 124 (21): 2075.

https://doi.org/10.1182/blood.V124.21.2075.2075

Published: 2014

Journal Articles

A Meta-Analysis Of Genome-Wide Association Studies Of Multiple Myeloma In Cases and Controls Of European Origin Identifies a Risk Locus In 12q23.1

Kristin A Rand, Ph.D., M.P.H., Nicola Camp, PhD, Alessandro Martino, Ph.D., Eric W. Dean, MD, Daniel J. Serie, Ph.D., Christopher K. Edlund, M.S., Donglei Hu, M.S., Karen Curtin, Ph.D., Scott Huntsman, MS, David J. Van Den Berg, Ph.D., Anneclaire De Roos, PhD, Elizabeth E Brown, Ph.D., Graham G. Giles, Ph.D., John J. Spinelli, Ph.D., Sikander Ailawadhi, M.D., Brenda M. Birmann, ScD, Angela R Brooks-Wilson, Ph.D., Richard K Severson, PhD, Paige M Bracci, PhD, Mulugeta Gebregziabher, PhD, Michael H. Tomasson, MD, Ann M. Mohrbacher, MD, Guido J. Tricot, M.D., Ph.D., Daniele Campa, M.D., Ph.D., Thomas Martin, III, M.D., Brian E. Henderson, M.D., Maurizio Zangari, MD, Nathaniel Rothman, MD, MPH, MHS, Stephen Jacob Chanock, MD, Shaji Kumar, MD, Laurence N. Kolonel, MD, PhD, Jeffrey Lee Wolf, MD, Graham A Colditz, M.D., Dr.PH., S. Vincent Rajkumar, MD, Nikhil C. Munshi, MD, Kenneth C. Anderson, MD, Christopher Haiman, Sc.D., David V. Conti, Ph.D., Federico Canzian, PhD, Celine M Vachon, PhD, Elad Ziv, MD, Wendy Cozen, D.O., M.P.H.

Blood (2013) 122 (21): 3111.

https://doi.org/10.1182/blood.V122.21.3111.3111

Published: 2013

Journal Articles

Deletion Of Samsn1 Underlies Genetic Susceptibility To Monoclonal Gammopathy Of Undetermined Significance (MGUS) In Mice

Sarah Amend, B.S., Liang Chu, PhD, Daniel Serie, PhD, Celine M Vachon, PhD, Lan Lu, MSci, Ravi Vij, MD, Graham A Colditz, M.D., Dr.PH., Katherine N Weilbaecher, MD, Michael H. Tomasson, MD

Blood (2013) 122 (21): 397.

https://doi.org/10.1182/blood.V122.21.397.397

Published: 2013

Journal Articles

Differences in the Distribution of Cytogenetic Subtypes Between Multiple Myeloma Patients with and without a History of Familial MGUS and Multiple Myeloma

Alexandra Greenberg, Margot Cousin, Celine M Vachon, PhD, Dirk Larson, Colin L. Colby, Shaji K. Kumar, MD, S. Vincent Rajkumar, MD

Blood (2012) 120 (21): 4000.

https://doi.org/10.1182/blood.V120.21.4000.4000

Published: 2012

Journal Articles

Prevalence of MBL Increases Over Time In Relatives of CLL Families,

Susan L Slager, PhD, Mark C Lanasa, MD, PhD, Sallie D. Allgood, MS, Sara J Achenbach, Aaron Norman, MS, Celine M Vachon, PhD, Lynn Goldin, PhD, Jose F. Leis, MD, PhD, Neil Kay, MD, J. Brice Weinberg, MD, Kari Rabe, MS, Timothy G. Call, MD, James R Cerhan, MD, PhD, Tait D. Shanafelt, MD, Neil E Caporaso, MD, Gerald E Marti, MD, PhD, Curtis A. Hanson, MD

Blood (2011) 118 (21): 3881.

https://doi.org/10.1182/blood.V118.21.3881.3881

Published: 2011

Journal Articles

Increased Risk of Monoclonal Gammopathy in First-Degree Relatives of Patients with Multiple Myeloma or Monoclonal Gammopathy of Undetermined Significance.

Celine M Vachon, PhD, Robert Kyle, MD, Terry Therneau, PhD, Dirk R Larson, Colin Colby, Barbara J Foreman, Angela Dispenzieri, MD, Shaji Kumar, MD, Jerry Katzmann, MD, S. Vincent Rajkumar, MD

Blood (2008) 112 (11): 1672.

https://doi.org/10.1182/blood.V112.11.1672.1672

Published: 2008

NARROW

Body Mass Index and Clinical Factors Associated with Monoclonal Gammopathy of Undetermined Significance (MGUS) Progression in Olmsted County, Minnesota

Prevalence of Familial Plasma Cell Disorders in Patients with Multiple Myeloma

Comparison of MGUS Prevalence By Race and Family History Risk Groups Using a High Sensitivity Screening Method (MASS-FIX)

Polygenic Risk Score and Risk of Chronic Lymphocytic Leukemia, Monoclonal B-Cell Lymphocytosis (MBL), and MBL Subtypes

The CCND1 870G Risk Allele Is Enriched in African Individuals with Plasma Cell Dyscrasias

Association between a Polygenic Risk Score for Multiple Myeloma Risk and Overall Survival

Germline Variation Predicts Treatment Response in Multiple Myeloma

Tumor Mutational Load and Germline Polygenic Risk Score Predicts Time-to-First Treatment in Chronic Lymphocytic Leukemia (CLL) and High-Count Monoclonal B Cell Lymphocytosis (MBL)

Large-Scale Linkage Analysis of Multiple Myeloma (MM) and Monoclonal Gammopathy of Undetermined Significance (MGUS) Families

Genomic Abnormalities Among African Individuals with Monoclonal Gammopathies Using Calculated Ancestry

Clonal Hematopoiesis of Indeterminate Potential (CHIP) and Chronic Lymphocytic Leukemia (CLL) Driver Genes: Risk of CLL and Monoclonal B-Cell Lymphocytosis (MBL)

Skin Cancers Among Chronic Lymphocytic Leukemia (CLL) Patients - the Effect of UV Radiation and CLL Clinical Characteristics

Risk of Monoclonal Gammopathy of Undetermined Significance in First-Degree Relatives of Multiple Myeloma Cases By Cytogenetic Subtype

Exome Sequencing in Chronic Lymphocytic Leukemia (CLL) and Multiple Myeloma (MM) Families Identifies Cosegregating Functional Variants

Inherited Loss of Samsn1 Contributes to Increased Risk of MGUS and MM through Effects on Multiple Cell Types, Including B-Cells, Transformed Myeloma Cells, and Macrophages

A Meta-Analysis Of Genome-Wide Association Studies Of Multiple Myeloma In Cases and Controls Of European Origin Identifies a Risk Locus In 12q23.1

Deletion Of Samsn1 Underlies Genetic Susceptibility To Monoclonal Gammopathy Of Undetermined Significance (MGUS) In Mice

Differences in the Distribution of Cytogenetic Subtypes Between Multiple Myeloma Patients with and without a History of Familial MGUS and Multiple Myeloma

Prevalence of MBL Increases Over Time In Relatives of CLL Families,

Increased Risk of Monoclonal Gammopathy in First-Degree Relatives of Patients with Multiple Myeloma or Monoclonal Gammopathy of Undetermined Significance.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only